The American Cancer Society Cancer Action Network (ACS CAN) today released a report examining the most common patient barriers to cancer clinical trial enrollment. Made public at ACS CAN’s annual national policy forum, the report found only about one in four (27%) patients has access to clinical trials where they are being treated. Yet, if asked to enroll in an available trial, more than half of eligible patients typically agree to do so.
Cancer Research Funding Press Releases
The U.S. House of Representatives today passed an FY 18 federal budget, which includes; a $3 billion increase for medical research at the National Institutes of Health (NIH)—the largest such funding increase in 15 years; and a $275 million increase for the National Cancer Institute (NCI).
The bipartisan bill would advance pediatric cancer research and increase transparency and expertise for pediatric cancer research at the National Institutes of Health (NIH). Additionally, the legislation expands research into the long-term side effects of childhood cancer and its treatments
The administration released its FY19 budget today including a minimum $1 billion cut for medical research at the National Institutes of Health (NIH), down from what the House and Senate committees have approved for FY 18 funding levels.
Short-Term Funding Bill Prioritizes Increased Investment in Funding for Cancer Research, Protects Access to Health Care Services
Congress passed a short-term extension to the FY18 spending bill that allows for an increase of at least $1 billion for the National Institutes of Health (NIH) for each of the FY18 and FY19 years, includes two years of funding for Federally Qualified Health Centers (FQHCs) and an additional four years of funding for the Children’s Health Insurance Program (CHIP).
Congress today included funding to reauthorize the Children’s Health Insurance Program (CHIP) for six years as part of a short-term extension in the FY18 spending bill. However, lawmakers delayed consideration of renewed funding for Federally Qualified Health Centers (FQHCs) until later budget negotiations are completed.
The American Cancer Society Cancer Action Network (ACS CAN) sent a letter to House leadership and committee chairs asking that they reconsider provisions of their tax proposal that could harm cancer patients. Specifically, ACS CAN opposes eliminating the medical expense deduction and ending tax credits for developing so-called “orphan drugs”.
Senator Patty Murray Receives National Distinguished Advocacy Award for Championing Lifesaving Cancer Public Policy
U.S. Senator Patty Murray (D-WA) received the National Distinguished Advocacy Award, the most esteemed award presented by the American Cancer Society Cancer Action Network (ACS CAN) for her dedication to protecting patient access to adequate and affordable health care coverage, increasing federal cancer research funding and her career-long support for policies and programs intended to end death and suffering from cancer.
Eunice Hosttetter, a breast cancer survivor from Kirkland, Wash., was honored as the State Lead Ambassador of the Year by the American Cancer Society Cancer Action Network (ACS CAN) for her commitment to cancer advocacy.
Nearly 100 people attended today’s Florida Policy Forum on Clinical Trials in Jacksonville hosted by the American Cancer Society Cancer Action Network (ACS CAN). The event brought together Florida research experts, government officials, patients and leaders from the cancer community to raise awareness about clinical trials in the state and review strategies for recruiting more diverse participants.